LUNGLIFE AI INC. DL-,0001
LUNGLIFE AI INC. DL-,0001
Share · USU5500L1045 · A3CY3X (XLON)
Overview
No Price
n/a
Company Profile for LUNGLIFE AI INC. DL-,0001 Share
LungLife AI, Inc., a cancer diagnostics company, develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology. It engages in developing LungLB, an AI enhanced, blood-based test to utilize machine learning to identify and count CTCs with reducing operator hands-on time and increasing test performance. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. The company is based in Thousand Oaks, California.
Get up to date insights from finAgent about LUNGLIFE AI INC. DL-,0001

Company Data

Name LUNGLIFE AI INC. DL-,0001
Company LungLife AI, Inc.
Website https://www.lunglifeai.com
Primary Exchange XLON Frankfurt
WKN A3CY3X
ISIN USU5500L1045
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Paul Pagano
Country United States of America
Currency EUR
Employees 0,0 T
Address 2545 West Hillcrest Drive, 91320 Thousand Oaks
IPO Date 2021-07-08

Ticker Symbols

Name Symbol
Frankfurt 9H4.F
London LLAI.L
More Shares
Investors who hold LUNGLIFE AI INC. DL-,0001 also have the following shares in their portfolio:
ELANCO ANIMAL HEALTH INC 5.00% TANGIBLE EQUITY UNITS
ELANCO ANIMAL HEALTH INC 5.00% TANGIBLE EQUITY UNITS Share
MAS Financial Services Limited
MAS Financial Services Limited Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025